We found that anti-tumor activity of DSP-0509 tended to be stronger in the tumor-bearing mouse model with high CD8+ T cell infiltration and weaker in the tumor-bearing mouse model with low CD8+ T cell infiltration. This evidence concerns the gene CD8A and neoplasm.